Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

United Therapeutics Pre-Tax Profit Margin 2011-2025 | UTHR

Current and historical pre-tax profit margin for United Therapeutics (UTHR) from 2011 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. United Therapeutics pre-tax profit margin for the three months ending September 30, 2025 was .
United Therapeutics Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2025-09-30 $3.13B $1.67B 53.28%
2025-06-30 $3.08B $1.62B 52.57%
2025-03-31 $2.99B $1.57B 52.27%
2024-12-31 $2.88B $1.54B 53.51%
2024-09-30 $2.76B $1.44B 52.16%
2024-06-30 $2.62B $1.40B 53.53%
2024-03-31 $2.50B $1.38B 55.26%
2023-12-31 $2.33B $1.27B 54.73%
2023-09-30 $2.21B $1.16B 52.52%
2023-06-30 $2.11B $1.12B 52.98%
2023-03-31 $1.98B $0.94B 47.17%
2022-12-31 $1.94B $0.95B 49.15%
2022-09-30 $1.86B $0.91B 49.14%
2022-06-30 $1.79B $0.81B 45.00%
2022-03-31 $1.77B $0.87B 49.24%
2021-12-31 $1.69B $0.60B 35.29%
2021-09-30 $1.66B $0.57B 34.30%
2021-06-30 $1.59B $0.58B 36.64%
2021-03-31 $1.51B $0.50B 33.20%
2020-12-31 $1.48B $0.64B 43.09%
2020-09-30 $1.41B $0.59B 42.09%
2020-06-30 $1.43B $0.54B 37.81%
2020-03-31 $1.44B $0.66B 45.53%
2019-12-31 $1.45B $-0.17B -11.45%
2019-09-30 $1.52B $-0.14B -9.34%
2019-06-30 $1.53B $-0.17B -11.04%
2019-03-31 $1.60B $-0.20B -12.55%
2018-12-31 $1.63B $0.76B 46.62%
2018-09-30 $1.71B $0.81B 47.20%
2018-06-30 $1.75B $0.99B 56.68%
2018-03-31 $1.75B $0.82B 46.70%
2017-12-31 $1.73B $0.77B 44.59%
2017-09-30 $1.67B $0.80B 47.94%
2017-06-30 $1.63B $0.72B 44.03%
2017-03-31 $1.60B $0.96B 60.02%
2016-12-31 $1.60B $1.06B 66.35%
2016-09-30 $1.60B $1.05B 65.52%
2016-06-30 $1.57B $1.54B 98.09%
2016-03-31 $1.51B $1.43B 94.56%
2015-12-31 $1.47B $1.04B 71.21%
2015-09-30 $1.41B $1.06B 75.55%
2015-06-30 $1.35B $0.29B 21.47%
2015-03-31 $1.33B $0.30B 22.23%
2014-12-31 $1.29B $0.53B 40.76%
2014-09-30 $1.23B $0.32B 25.83%
2014-06-30 $1.20B $0.46B 37.82%
2014-03-31 $1.16B $0.40B 34.54%
2013-12-31 $1.12B $0.28B 24.98%
2013-09-30 $1.07B $0.44B 40.67%
2013-06-30 $1.01B $0.44B 43.77%
2013-03-31 $0.96B $0.43B 44.62%
2012-12-31 $0.92B $0.44B 48.03%
2012-09-30 $0.87B $0.37B 43.14%
2012-06-30 $0.83B $0.36B 44.01%
2012-03-31 $0.79B $0.37B 47.26%
2011-12-31 $0.74B $0.30B 40.19%
2011-09-30 $0.71B $0.25B 35.35%
2011-06-30 $0.68B $0.21B 31.17%
2011-03-31 $0.63B $0.16B 25.16%
2010-12-31 $0.59B $0.16B 26.09%
2010-09-30 $0.53B $0.14B 26.18%
2010-06-30 $0.46B $0.09B 19.61%
2010-03-31 $0.41B $0.03B 6.62%
2009-12-31 $0.36B $0.02B 5.01%
2009-09-30 $0.34B $-0.11B -33.23%
2009-06-30 $0.32B $-0.10B -33.02%
2009-03-31 $0.30B $-0.08B -26.33%
2008-12-31 $0.28B $-0.08B -29.79%
2008-09-30 $0.27B $0.03B 12.78%
2008-06-30 $0.25B $0.03B 13.60%
2008-03-31 $0.23B $0.02B 10.30%
2007-12-31 $0.21B $0.00B 2.37%
2007-09-30 $0.20B $0.03B 15.23%
2007-06-30 $0.18B $0.03B 15.17%
2007-03-31 $0.17B $0.03B 19.28%
2006-12-31 $0.16B $0.04B 25.16%
2006-09-30 $0.14B $0.04B 30.77%
2006-06-30 $0.14B $0.05B 33.82%
2006-03-31 $0.13B $0.04B 34.92%
2005-12-31 $0.12B $0.05B 41.38%
2005-09-30 $0.11B $0.04B 39.81%
2005-06-30 $0.10B $0.03B 34.74%
2005-03-31 $0.08B $0.03B 30.12%
2004-12-31 $0.07B $0.02B 20.27%
2004-09-30 $0.07B $0.01B 7.58%
2004-06-30 $0.06B $0.00B -3.28%
2004-03-31 $0.06B $-0.01B -14.04%
2003-12-31 $0.05B $-0.01B -16.67%
2003-09-30 $0.05B $-0.01B -17.31%
2003-06-30 $0.04B $-0.02B -47.62%
2003-03-31 $0.04B $-0.02B -52.50%
2002-12-31 $0.03B $-0.02B -80.00%
2002-09-30 $0.02B $-0.03B -140.00%
2002-06-30 $0.02B $-0.03B -162.50%
2002-03-31 $0.01B $-0.03B -680.00%
2001-12-31 $0.01B $-0.04B -740.00%
2001-09-30 $0.00B $-0.06B -1550.00%
2001-06-30 $0.00B $-0.06B -1966.67%
2001-03-31 $0.00B $-0.08B -2566.67%
2000-12-31 $0.00B $-0.08B -3800.00%
2000-09-30 $0.00B $-0.04B -4400.00%
2000-06-30 $0.00B $-0.04B -4300.00%
2000-03-31 $0.00B $-0.02B 0.00%
1999-12-31 $0.00B $-0.01B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $19.329B $2.877B
United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $79.709B 30.27
Zoetis (ZTS) United States $52.989B 18.97
Takeda Pharmaceutical (TAK) Japan $43.466B 8.87
Daiichi Sankyo, - (DSNKY) Japan $41.562B 20.70
BeOne Medicines - (ONC) Switzerland $35.089B 186.03
Sandoz Group AG (SDZNY) Switzerland $29.014B 0.00
Merck (MKKGY) Germany $16.401B 10.66
Neurocrine Biosciences (NBIX) United States $15.192B 36.45
Shionogi (SGIOY) Japan $14.411B 13.23
Summit Therapeutics (SMMT) United States $14.020B 0.00
Ionis Pharmaceuticals (IONS) United States $11.913B 0.00
IPSEN (IPSEY) France $11.841B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.112B 0.00
Orion OYJ (ORINY) Finland $8.719B 24.91
Eisai (ESAIY) $8.166B 0.00
Corcept Therapeutics (CORT) United States $7.754B 83.77
Stevanato Group S.p.A (STVN) Italy $7.299B 40.85
Grifols, S.A (GRFS) Spain $5.803B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.730B 17.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.546B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.140B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.767B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.571B 16.97
Centessa Pharmaceuticals (CNTA) United Kingdom $2.962B 0.00
Hypermarcas (HYPMY) Brazil $2.958B 22.24
Catalyst Pharmaceuticals (CPRX) United States $2.629B 8.39
Dyne Therapeutics (DYN) United States $2.622B 0.00
Soleno Therapeutics (SLNO) United States $2.562B 0.00
Ocular Therapeutix (OCUL) United States $2.312B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.926B 22.83
Guardian Pharmacy Services (GRDN) United States $1.824B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.815B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.493B 88.62
Ardelyx (ARDX) United States $1.358B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.352B 0.00
Collegium Pharmaceutical (COLL) United States $1.337B 6.62
Harrow (HROW) United States $1.255B 0.00
Xeris Biopharma Holdings (XERS) United States $1.233B 0.00
Oruka Therapeutics (ORKA) United States $1.153B 0.00
Evotec AG (EVO) Germany $1.094B 0.00
Nektar Therapeutics (NKTR) United States $1.064B 0.00
Relay Therapeutics (RLAY) United States $1.049B 0.00
Enliven Therapeutics (ELVN) United States $1.044B 0.00
Xencor (XNCR) United States $0.993B 0.00
Cronos Group (CRON) Canada $0.950B 0.00
ARS Pharmaceuticals (SPRY) United States $0.875B 0.00
ProKidney (PROK) United States $0.850B 0.00
Theravance Biopharma (TBPH) United States $0.743B 61.46
Aquestive Therapeutics (AQST) United States $0.737B 0.00
Organogenesis (ORGO) United States $0.714B 0.00
Savara (SVRA) United States $0.683B 0.00
Elite Pharmaceuticals (ELTP) United States $0.674B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.639B 5.70
Bioventus (BVS) United States $0.616B 12.63
KalVista Pharmaceuticals (KALV) United States $0.545B 0.00
Akebia Therapeutics (AKBA) United States $0.541B 0.00
Esperion Therapeutics (ESPR) United States $0.536B 0.00
Zevra Therapeutics (ZVRA) United States $0.496B 0.00
4D Molecular Therapeutics (FDMT) United States $0.490B 0.00
Siga Technologies (SIGA) United States $0.468B 6.41
Lexeo Therapeutics (LXEO) United States $0.442B 0.00
Altimmune (ALT) United States $0.429B 0.00
USANA Health Sciences (USNA) United States $0.350B 9.76
Lyell Immunopharma (LYEL) United States $0.336B 0.00
Galectin Therapeutics (GALT) United States $0.335B 0.00
Korro Bio (KRRO) United States $0.318B 0.00
Nature's Sunshine Products (NATR) United States $0.314B 18.67
Ironwood Pharmaceuticals (IRWD) United States $0.312B 48.00
Larimar Therapeutics (LRMR) United States $0.286B 0.00
Aldeyra Therapeutics (ALDX) United States $0.282B 0.00
Aclaris Therapeutics (ACRS) United States $0.251B 0.00
Achieve Life Sciences (ACHV) Canada $0.244B 0.00
Pyxis Oncology (PYXS) United States $0.243B 0.00
Journey Medical (DERM) United States $0.240B 0.00
AleAnna (ANNA) United States $0.212B 0.00
Heron Therapeutics (HRTX) United States $0.202B 0.00
OmniAb (OABI) United States $0.199B 0.00
Avalo Therapeutics (AVTX) United States $0.198B 0.00
MediWound (MDWD) Israel $0.195B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
Protara Therapeutics (TARA) United States $0.166B 0.00
China SXT Pharmaceuticals (SXTC) China $0.159B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.149B 0.00
Cassava Sciences (SAVA) United States $0.143B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.129B 0.00
Incannex Healthcare (IXHL) Australia $0.121B 0.00
Inhibikase Therapeutics (IKT) United States $0.112B 0.00
Surrozen (SRZN) United States $0.105B 0.00
Context Therapeutics (CNTX) United States $0.103B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
Avita Medical (RCEL) United States $0.100B 0.00
Vivani Medical (VANI) United States $0.096B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Champions Oncology (CSBR) United States $0.093B 33.70
Karyopharm Therapeutics (KPTI) United States $0.088B 0.00
Relmada Therapeutics (RLMD) United States $0.088B 0.00
Unicycive Therapeutics (UNCY) United States $0.082B 0.00
Metagenomi (MGX) United States $0.081B 0.00
Dominari Holdings (DOMH) United States $0.076B 0.00
Lite Strategy (LITS) United States $0.075B 0.00
Plus Therapeutics (PSTV) United States $0.074B 0.00
Assertio Holdings (ASRT) United States $0.073B 0.00
Nutriband (NTRB) United States $0.073B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.071B 0.00
Gain Therapeutics (GANX) United States $0.070B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Prelude Therapeutics (PRLD) United States $0.067B 0.00
Rafael Holdings (RFL) United States $0.067B 0.00
BioNxt Solutions (BNXTF) Canada $0.060B 0.00
Acrivon Therapeutics (ACRV) United States $0.059B 0.00
PolyPid (PYPD) Israel $0.058B 0.00
Talphera (TLPH) United States $0.058B 0.00
Wellgistics Health (WGRX) United States $0.057B 0.00
Fractyl Health (GUTS) United States $0.055B 0.00
NRx Pharmaceuticals (NRXP) United States $0.049B 0.00
ElectroCore (ECOR) United States $0.047B 0.00
Jupiter Neurosciences (JUNS) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.046B 0.00
FibroGen (FGEN) United States $0.045B 0.00
Telomir Pharmaceuticals (TELO) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Inotiv (NOTV) United States $0.040B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Klotho Neurosciences (KLTO) United States $0.033B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.033B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.032B 26.62
Liminatus Pharma (LIMN) United States $0.032B 0.00
Iterum Therapeutics (ITRM) Ireland $0.029B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Mangoceuticals (MGRX) United States $0.023B 0.00
Cosmos Health (COSM) United States $0.021B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Vyome Holdings (HIND) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Heatwurx (PCSA) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Lipocine (LPCN) United States $0.014B 0.00
Traws Pharma (TRAW) United States $0.014B 0.02
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CDT Equity (CDT) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.99
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00